GlassScriptPhysician profile
Bradley James Petty
NPI 1790103976
$1,862.84
in general payments reported to CMS, 2019-2025
12 companies · $32.59 in 2025
The $32.59 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,250 · 2020: $70.72 · 2021: $14.40 · 2022: $86.29 · 2023: $163 · 2024: $246 · 2025: $32.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $747.75 | 2019 | |
| Smith+Nephew, INC. | $330.53 | 2019-2021 | |
| Inspire Medical Systems, INC. | $221.09 | 2024 | Inspire |
| Acclarent, INC | $126.17 | 2019 | |
| Medtronic, INC. | $105.90 | 2023-2024 | N/A, Pteye Parathyroid Detection System |
| Livanova USA, INC. | $67.02 | 2020-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Stryker Corporation | $61.83 | 2020-2022 | |
| Olympus America INC. | $60.58 | 2019-2022 | |
| Aerin Medical INC. | $56.93 | 2023-2025 | |
| Genzyme Corporation | $40.25 | 2023 | |
| Intersect Ent, INC. | $26.92 | 2019 | |
| Phadia US INC. | $17.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Petty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.